Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth
Alex C Vidaeff, Michael A BelfortDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USAAbstract: Prevention of preterm delivery is a major desiderate in contemporary obstetrics and a societal ne...
Main Authors: | Vidaeff AC, Belfort MA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-07-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/critical-appraisal-of-the-efficacy-safety-and-patient-acceptability-of-a13637 |
Similar Items
-
Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
Published: (2021-07-01) -
Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth
by: Travanty MN, et al.
Published: (2018-07-01) -
Understanding barriers to utilization of 17-hydroxyprogesterone caproate and other interventions to prevent preterm birth in Fresno County, California
by: Subhashini Ladella, et al.
Published: (2021-08-01) -
Does hydroxyprogesterone caproate injection alter second trimester screening markers and neonatal outcomes?
by: İlknur Çöl Madendağ, et al.
Published: (2019-01-01) -
Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy
by: Kim A. Boggess, et al.
Published: (2018-04-01)